Bausch Health Cos., Inc.
(NYSE : BHC)

( )
BHC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.19%178.886.2%$86.86m
AMRNAmarin Corporation Plc Sponsored ADR
-5.40%16.831.8%$86.22m
SAGESAGE Therapeutics, Inc.
-2.72%163.418.8%$71.51m
PRGOPerrigo Co. Plc
-0.18%49.586.8%$70.66m
ICPTIntercept Pharmaceuticals, Inc.
-1.71%84.9418.6%$67.92m
JAZZJazz Pharmaceuticals Plc
-0.60%138.332.3%$64.12m
UTHRUnited Therapeutics Corporation
-3.03%87.9014.3%$58.52m
ZYNEZynerba Pharmaceuticals Inc
-6.27%14.518.3%$47.23m
ICLRICON Plc
-0.14%137.284.1%$43.66m
MNKMallinckrodt Plc
-11.24%13.0321.0%$39.11m
CTLTCatalent Inc
0.04%45.392.4%$37.97m
MDCOMedicines Company
3.76%34.2321.8%$35.99m
PCRXPacira Pharmaceuticals, Inc.
-0.94%43.3210.5%$35.63m
HZNPHorizon Pharma plc
-1.90%25.346.7%$34.69m
AXSMAxsome Therapeutics, Inc.
-1.65%22.702.1%$30.47m

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.